Article: Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature.
Antibiotics (Basel, Switzerland)
2023 Volume 12, Issue 8
Abstract: Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and ... ...
Abstract | Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and safety of ceftazidime-avibactam as a therapy for osteomyelitis and prosthetic joint infections. Here, we present three cases of difficult-to-treat resistant |
---|---|
Language | English |
Publishing date | 2023-08-17 |
Publishing country | Switzerland |
Document type | Case Reports |
ZDB-ID | 2681345-2 |
ISSN | 2079-6382 |
ISSN | 2079-6382 |
DOI | 10.3390/antibiotics12081328 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.